Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

HSPC111 governs breast cancer growth by regulating ribosomal biogenesis.

Zhang C, Yin C, Wang L, Zhang S, Qian Y, Ma J, Zhang Z, Xu Y, Liu S.

Mol Cancer Res. 2014 Apr;12(4):583-94. doi: 10.1158/1541-7786.MCR-13-0168. Epub 2014 Jan 14.

2.

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.

Butt AJ, Sergio CM, Inman CK, Anderson LR, McNeil CM, Russell AJ, Nousch M, Preiss T, Biankin AV, Sutherland RL, Musgrove EA.

Breast Cancer Res. 2008;10(2):R28. doi: 10.1186/bcr1985. Epub 2008 Mar 29.

3.

Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells.

Belin S, Beghin A, Solano-Gonzàlez E, Bezin L, Brunet-Manquat S, Textoris J, Prats AC, Mertani HC, Dumontet C, Diaz JJ.

PLoS One. 2009 Sep 25;4(9):e7147. doi: 10.1371/journal.pone.0007147.

4.

ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc.

Zhang C, Zhang S, Zhang Z, He J, Xu Y, Liu S.

Oncogene. 2014 Dec 4;33(49):5582-91. doi: 10.1038/onc.2013.505. Epub 2013 Dec 9.

PMID:
24317511
5.

JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.

Penzo M, Casoli L, Pollutri D, Sicuro L, Ceccarelli C, Santini D, Taffurelli M, Govoni M, Brina D, Trerè D, Montanaro L.

Int J Cancer. 2015 Mar 1;136(5):E272-81. doi: 10.1002/ijc.29240. Epub 2014 Oct 10.

6.

Quantum dots (QDs) restrain human cervical carcinoma HeLa cell proliferation through inhibition of the ROCK-c-Myc signaling.

Chen L, Qu G, Zhang C, Zhang S, He J, Sang N, Liu S.

Integr Biol (Camb). 2013 Mar;5(3):590-6. doi: 10.1039/c2ib20269g.

PMID:
23370637
7.

Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.

Ray S, Johnston R, Campbell DC, Nugent S, McDade SS, Waugh D, Panov KI.

Gene. 2013 Aug 15;526(1):46-53. doi: 10.1016/j.gene.2013.04.018. Epub 2013 Apr 19.

PMID:
23608168
8.

AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.

Chan JC, Hannan KM, Riddell K, Ng PY, Peck A, Lee RS, Hung S, Astle MV, Bywater M, Wall M, Poortinga G, Jastrzebski K, Sheppard KE, Hemmings BA, Hall MN, Johnstone RW, McArthur GA, Hannan RD, Pearson RB.

Sci Signal. 2011 Aug 30;4(188):ra56. doi: 10.1126/scisignal.2001754.

9.

Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells.

Ludyga N, Anastasov N, Rosemann M, Seiler J, Lohmann N, Braselmann H, Mengele K, Schmitt M, Höfler H, Aubele M.

Mol Cancer Res. 2013 Apr;11(4):381-92. doi: 10.1158/1541-7786.MCR-12-0378. Epub 2013 Jan 30.

10.

Hepatitis B virus X protein and c-Myc cooperate in the upregulation of ribosome biogenesis and in cellular transformation.

Shukla SK, Kumar V.

FEBS J. 2012 Oct;279(20):3859-71. doi: 10.1111/j.1742-4658.2012.08745.x. Epub 2012 Sep 7.

11.

Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients.

Huang S, Zhu L, Cao Y, Li L, Xie Y, Deng J, Xiong J.

Oncotarget. 2017 May 17;8(46):80303-80314. doi: 10.18632/oncotarget.17932. eCollection 2017 Oct 6.

13.

AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo.

Devlin JR, Hannan KM, Ng PY, Bywater MJ, Shortt J, Cullinane C, McArthur GA, Johnstone RW, Hannan RD, Pearson RB.

FEBS J. 2013 Nov;280(21):5307-16. doi: 10.1111/febs.12135. Epub 2013 Feb 13.

14.

Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis.

Drygin D, Siddiqui-Jain A, O'Brien S, Schwaebe M, Lin A, Bliesath J, Ho CB, Proffitt C, Trent K, Whitten JP, Lim JK, Von Hoff D, Anderes K, Rice WG.

Cancer Res. 2009 Oct 1;69(19):7653-61. doi: 10.1158/0008-5472.CAN-09-1304. Epub 2009 Sep 8.

15.

Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis.

Tan JX, Wang XY, Su XL, Li HY, Shi Y, Wang L, Ren GS.

PLoS One. 2011;6(7):e22836. doi: 10.1371/journal.pone.0022836. Epub 2011 Jul 28.

16.

Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation.

Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S, Hu GF.

Cancer Res. 2005 Feb 15;65(4):1352-60.

17.

Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.

Fisher JL, Thomas-Mudge RJ, Elliott J, Hards DK, Sims NA, Slavin J, Martin TJ, Gillespie MT.

Cancer Res. 2006 Apr 1;66(7):3620-8.

18.

Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.

Rucci N, Millimaggi D, Mari M, Del Fattore A, Bologna M, Teti A, Angelucci A, Dolo V.

Cancer Res. 2010 Aug 1;70(15):6150-60. doi: 10.1158/0008-5472.CAN-09-2758. Epub 2010 Jul 14.

19.

siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model.

Liang Y, Gao H, Lin SY, Goss JA, Brunicardi FC, Li K.

PLoS One. 2010 Sep 20;5(9):e12860. doi: 10.1371/journal.pone.0012860.

20.

Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.

Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, Zeng YX, Shao JY.

Breast Cancer Res. 2011 Jan 10;13(1):R2. doi: 10.1186/bcr2803.

Supplemental Content

Support Center